# S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed

> **NCT00002593** · PHASE3 · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 1135 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** fluorouracil
- **DRUG:** leucovorin calcium
- **DRUG:** levamisole hydrochloride

## Key facts

- **NCT ID:** NCT00002593
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-12
- **Primary completion:** 1999-12
- **Final completion:** 2005-03
- **Target enrollment:** 1135 (ACTUAL)
- **Last updated:** 2013-01-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002593, "S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00002593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*